The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


YENTREVE

40 Milligram Capsules Gastro-Resistant

Eli Lilly Nederland B.V.EU/1/04/280/1-6

Main Information

Trade NameYENTREVE
Active SubstancesDULOXETINE HYDROCHLORIDE
Strength40 Milligram
Dosage FormCapsules Gastro-Resistant
Licence HolderEli Lilly Nederland B.V.
Licence NumberEU/1/04/280/1-6

Group Information

ATC CodeN06AX21 duloxetine

Status

Authorised/WithdrawnAuthorised
Licence Issued11/08/2004
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website

Generics Information

Interchangeable List CodeIC0091-004-006
Interchangeable List DocumentPDF of Interchangeable List
« Back